Home Microbiology RSV

RSV

RSV Products

  • All (4)
  • RSV Inhibitors (3)
  • RSV Antibodie (1)
  • New RSV Products
Catalog No. Product Name Information Product Use Citations Product Validations
S8588 ACSS2 inhibitor ACSS2 inhibitor is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2). ACSS2 inhibitor also inhibits the respiratory syncytial virus (RSV).
Nat Commun, 2024, 15(1):3200
Research (Wash D C), 2024, 7:0400
Cell Commun Signal, 2024, 22(1):187
S0470 RSV604 RSV604 (A-60444), a novel benzodiazepine, is an inhibitor of respiratory syncytial virus (RSV) with EC50 of 0.86 μM. RSV604 has significant potential for the effective treatment of RSV disease. Phase 2.
Biomed Environ Sci, 2023, 36(2):135-145
E1398 Rilematovir Rilematovir (JNJ-678, JNJ-53718678) is an antiviral agent that inhibits respiratory syncytial virus (RSV) with EC50 of 1.2 nM in HBECs. Rilematovir is also a fusion protein inhibitor.
A2364 Palivizumab (Anti-RSV-F) Palivizumab (Anti-RSV-F) is a humanized monoclonal antibody against the fusion protein (F protein) of human respiratory syncytial virus (RSV), with prophylactic application in respiratory syncytial virus infections. MW : 145.5 kD.
S8588 ACSS2 inhibitor ACSS2 inhibitor is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2). ACSS2 inhibitor also inhibits the respiratory syncytial virus (RSV).
Nat Commun, 2024, 15(1):3200
Research (Wash D C), 2024, 7:0400
Cell Commun Signal, 2024, 22(1):187
S0470 RSV604 RSV604 (A-60444), a novel benzodiazepine, is an inhibitor of respiratory syncytial virus (RSV) with EC50 of 0.86 μM. RSV604 has significant potential for the effective treatment of RSV disease. Phase 2.
Biomed Environ Sci, 2023, 36(2):135-145
E1398 Rilematovir Rilematovir (JNJ-678, JNJ-53718678) is an antiviral agent that inhibits respiratory syncytial virus (RSV) with EC50 of 1.2 nM in HBECs. Rilematovir is also a fusion protein inhibitor.
A2364 Palivizumab (Anti-RSV-F) Palivizumab (Anti-RSV-F) is a humanized monoclonal antibody against the fusion protein (F protein) of human respiratory syncytial virus (RSV), with prophylactic application in respiratory syncytial virus infections. MW : 145.5 kD.

Choose Selective RSV Inhibitors

Tags: RSV inhibitor|RSV agonist|RSV activator|RSV inducer|RSV antagonist|RSV signaling pathway|RSV assay kit